C-reactive protein (CRP) is a blood marker produced by the liver during inflammation. Elevated levels signal ongoing immune activity, which may indicate infection, injury, autoimmune disorders, or cardiovascular risk. A CRP test measures this protein to assess systemic inflammation.
CRP is synthesized in response to interleukin-6 (IL-6), a cytokine released during tissue damage or infection. The liver detects IL-6 and ramps up CRP production within hours. This makes CRP one of the fastest-reacting biomarkers in clinical use. Unlike other markers, CRP doesn't distinguish between types of inflammation-it only confirms that inflammation is occurring.
Doctors use CRP to monitor disease progression and treatment response. For example, a patient with rheumatoid arthritis may have a baseline CRP of 50 mg/L. After starting biologic therapy, the level drops to 10 mg/L, indicating reduced inflammation. This trend helps clinicians adjust medication without relying solely on symptoms.
When tissues are damaged or pathogens invade, immune cells release signaling molecules like IL-6. These travel to the liver, triggering the synthesis of acute-phase proteins-including CRP. Within 4-6 hours of stimulus, CRP levels rise sharply, peaking around 48 hours.
CRP functions by binding to phosphocholine on damaged cells and microbes. This activates the complement system, enhancing phagocytosis-the process by which white blood cells engulf and destroy foreign material. By marking targets for immune clearance, CRP acts as a bridge between innate immunity and cellular cleanup.
Because CRP responds quickly, it's useful in emergency settings. A trauma patient with a CRP of 120 mg/L likely has a significant inflammatory response. If levels remain elevated past 72 hours, it suggests infection or poor healing. Conversely, a rapid decline after antibiotics confirms effective treatment.
There are two main forms of CRP testing:
| Test Type | Normal Range | Use Case | Key Limitation |
|---|---|---|---|
| Standard CRP | <10 mg/L | General inflammation screening | Cannot detect low-grade inflammation |
| High-sensitivity CRP (hs-CRP) | <2 mg/L | Cardiovascular risk assessment | Less accurate in severe infections |
Standard CRP tests are used in routine labs to detect acute inflammation. Levels above 10 mg/L suggest active infection or tissue injury. For example, a patient with pneumonia often shows CRP values between 50-200 mg/L.
High-sensitivity CRP (hs-CRP) measures lower concentrations with greater precision. It's used to evaluate long-term cardiovascular risk. According to the American Heart Association, individuals with hs-CRP above 3 mg/L face a 2.5 times higher risk of heart attack over ten years compared to those below 1 mg/L.
A common misconception is that CRP directly diagnoses specific diseases. It does not. A CRP of 80 mg/L tells you inflammation is present-but not whether it stems from appendicitis, lupus, or a recent surgery. Diagnosis requires clinical context, imaging, and additional lab work.
Many patients assume a high CRP means they have a serious illness. That's not always true. A 2019 study published in The Journal of Clinical Endocrinology & Metabolism found that 38% of patients with CRP levels above 50 mg/L had no identifiable infection or autoimmune condition. Instead, they were experiencing stress-related inflammation due to sleep deprivation or chronic pain.
Another frequent error is equating CRP with white blood cell count. Both reflect immune activation, but they're independent. A patient with sepsis may have a WBC of 18,000/μL and CRP of 200 mg/L-both elevated. But in viral infections, WBC stays normal while CRP rises. This difference helps doctors distinguish bacterial from viral causes.
I once reviewed a case where a 45-year-old woman presented with fatigue and joint pain. Her standard CRP was 45 mg/L, leading her primary care provider to suspect rheumatoid arthritis. However, a repeat test after two weeks showed a drop to 15 mg/L. Further investigation revealed she'd recently undergone dental extraction with subclinical infection. The CRP normalized once antibiotics were completed. This illustrates how CRP trends-not single values-are key to interpretation.
CRP is routinely ordered in emergency departments, intensive care units, and outpatient clinics. It's part of the initial workup for suspected infections, post-surgical monitoring, and chronic disease management.
For instance, a patient undergoing hip replacement surgery typically has a CRP drawn pre-op, then daily for three days post-op. A spike from 12 mg/L to 180 mg/L on day two raises red flags for surgical site infection. Early intervention reduces complications and hospital stay.
However, CRP cannot identify the source of inflammation. It also doesn't differentiate between acute and chronic inflammation. A person with Crohn's disease may have a stable CRP of 25 mg/L over months-indicating persistent immune activation-but no new flare-up signs. In such cases, other markers like erythrocyte sedimentation rate (ESR) or fecal calprotectin are needed.
One non-obvious fact: CRP levels can rise in response to psychological stress. A 2021 study in PLOS ONE showed that participants under acute mental stress had a 20% increase in CRP within 90 minutes. This underscores that CRP reflects physiological stress, not just physical injury.
If your CRP is mildly elevated (10-50 mg/L), your doctor may recommend lifestyle changes-better sleep, diet adjustments, or exercise-to reduce chronic inflammation. Persistent elevations above 100 mg/L require immediate investigation.
For cardiovascular risk, an hs-CRP above 3 mg/L warrants discussion about statin therapy, even if cholesterol levels are normal. The JUPITER trial demonstrated that people with LDL under 130 mg/dL but hs-CRP above 2 mg/L benefited from rosuvastatin, reducing heart attack risk by 44%.
Never interpret CRP alone. Always consider symptoms, medical history, and other lab results. If you're unsure about your result, ask your provider: "Is this level consistent with my current symptoms?" or "Should we check for underlying infection or autoimmune disease?"